Next Generation Regulatory T cell Therapy

Thursday, June 15
1:00 PM - 1:25 PM

Learning Objectives:

Megan K. Levings

University of British Columbia
University of British Columbia

Megan K. Levings, PhD
Professor, Dept of Surgery, University of British Columbia
Head, Childhood Diseases Theme, BC Children’s Hospital Research Institute

Dr. Megan Levings has been in the UBC Department of Surgery since 2003 when she was recruited back to Canada as a Canada Research Chair in Transplantation. In 2011 she joined the BC Children’s Hospital Research Institute where she now heads the Childhood Diseases Theme. Dr. Levings’ scientific career started with summer research positions in a fruit fly genetics lab at Simon Fraser University. She then did her graduate training in the genetics program with Dr. John Schrader at UBC. In 1999 she joined Dr. Maria Grazia Roncarolo's lab in Milan, Italy, undertaking postdoctoral training in the emerging area of immune regulation. She was among the first groups to show that a special kind of white blood cell, known as a T regulatory cell, could be used as a therapy to stop harmful immune responses. She continues this line of research at UBC, and is now internationally recognized in the field of human immunology and chairs the Federation of Clinical Immunology Societies Centres of Excellence. She leads a vibrant group of trainees and staff who are researching how to use T regulatory cells to replace conventional immunosuppression in the context of transplantation and autoimmunity.


Send Email for Megan Levings


Next Generation Regulatory T cell Therapy

Attendees who have favorited this

Send Email for Next Generation Regulatory T cell Therapy